Cardiac MRI in Ischemic Stroke Study
Completed
- Conditions
- Stroke
- Registration Number
- NCT01917955
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.
- Detailed Description
Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal echocardiography in patients with acute ischemic stroke.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 103
Inclusion Criteria
- Patients with acute ischemic stroke detected by brain magnetic resonance imaging.
Exclusion Criteria
- Known atrial fibrillation or cardiac source of embolism
- Severe aphasia
- Acute infection or chronic inflammation
- Severe arteriosclerosis or stenosis of brain-supplying arteries
- Contraindications for magnetic resonance imaging or transesophageal echocardiography.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke. < 1 week after ischemic stroke
- Secondary Outcome Measures
Name Time Method Rate of unrecognised myocardial infarction detected by late gadolinium-enhanced cardiac MRI in patients with acute ischemic stroke. < 1 week after ischemic stroke
Trial Locations
- Locations (2)
Elisabeth Hospital
🇩🇪Essen, Germany
Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin
🇩🇪Berlin, Germany